Daily TIP

The Daily TIP: Obama Administration Sought to Give Iran Access to Billions of U.S. Dollars

Posted by Tip Staff - June 07, 2018

Obama Administration Sought to Give Iran Access to Billions of U.S. Dollars
European Leaders Back Israel: Iranian Troops Must Leave Syria
Australian Forum Cancels Women’s March Leader after Anti-Israel Comments
Israeli Scientists Invent System to Deliver Cancer Drugs to Children Using Nanotechnology


Obama Administration Sought to Give Iran Access to Billions of U.S. Dollars

In order to free up money that Iran had in an Omani bank, the Obama administration sought to give Iran access to dollars — something it said it wouldn't do — in February 2016, shortly after the terms of the nuclear deal were implemented, the Associated Press reported Wednesday.

Iran had $5.7 billion in an Omani bank that needed to be converted to dollars, so it could then be converted to euros. Because the United States had promised Iran access to money it had in offshore accounts, the Obama administration secretly issued a license allowing Iran brief access to the U.S. currency to make the conversions possible.

The plan, which was revealed in a report by Senate Republicans released on Wednesday, failed when two American banks refused to participate.

The license to allow Oman’s Bank of Muscat to convert the funds in Omani rial to dollars and then to euros, was issued in February 2016. Had the bank attempted to do the conversions without a license, it would have violated sanctions that prohibit Iran from being involved in any transactions with the U.S. financial system.

The AP described the conversion of the fund into dollars as "the easiest and most efficient way to speed up Iran’s access" to the money in the Omani bank.

The AP reported that while it was not illegal for the administration to issue the license, it nonetheless "went above and beyond what the Obama administration was required to do under the terms of the nuclear agreement."



European Leaders Back Israel: Iranian Troops Must Leave Syria

A senior Israeli official said Wednesday there is “widespread agreement” among European leaders – German Chancellor Angela Merkel, French President Emmanuel Macron, and British Prime Minister Theresa May — that Iranian troops must be entirely removed from Syria, The Times of Israel reported.

As Prime Minister Benjamin Netanyahu’s diplomatic trip to Berlin, Paris and London approached a close, the Israeli official said there had been “significant progress,” on issues related to Iran. The senior diplomat also said that the three European leaders agreed to Israel’s demand to have the UN’s International Atomic Energy Agency (IAEA) review the Iranian nuclear archives obtained by the Mossad earlier this year.

Before setting out on his trip to Europe, Netanyahu had indicated that Iran would be the first and only subject on his agenda in meetings with European leaders.

When speaking to journalists in London, the Prime Minister said, “my main goal was to bring international agreement that Iran would leave Syria,” and “to harness the leading European countries to oppose the continued expansion of Iran.” He added that Israel’s goal was “To prevent the nuclear program and to smash the cash machine that finances this empire.”

Merkel, in a meeting with Netanyahu on Monday, told her Israeli counterpart that she agrees with Israel’s demand that Iranian forces be removed from Syria, especially in the southwest of the country near the Israeli border.



Australian Forum Cancels Women’s March Leader after Anti-Israel Comments

After calling the establishment of Israel a "human rights crime," Tamika Mallory, a leader of the Women's March, who supports Rev. Louis Farrakhan, was disinvited to speak next week at an event hosted by an Australian social service agency, The Jerusalem Post reported Wednesday.

The Victorian Council of Social Service (VCOSS) had invited Mallory to speak at its "Good Life" summit in Melbourne. However, Jews in Australia raised their concerns about Mallory's ties to Farrakhan, an anti-Semite, in addition to her comments disparaging Israel.

Mallory had recently traveled to the Middle East under the auspices of a Manhattan-based group, the Center for Constitutional Rights. During her trip, she met only with Palestinians and pro-Palestinian activists. In a speech at the Center last Friday upon her return, Mallory seemed to acknowledge a right for a Jewish homeland, but then she said, "But you don’t show up to somebody’s home, needing a place to stay, and decide that you’re going to throw them out and hurt the people who are on that land. And to kill, steal, and do whatever it is you’re gonna do to take that land. That to me is unfair. It’s a human rights crime."

A spokesman for VCOSS told The Australian that the group feared that Mallory's remarks would "overshadow" the event. "VCOSS is concerned both by comments Ms Mallory made in recent days regarding Israeli-Palestinian affairs, and the capacity for these remarks to overshadow the Good Life Summit."



Israeli Scientists Invent System to Deliver Cancer Drugs to Children Using Nanotechnology

A nanotech system invented in Israel for transporting anticancer drugs specifically in pediatric patients has been shown to slow tumor growth and prolong life expectancy in engineered mice by 42 percent. In most of the Western world, cancer is the primary cause of death in children over the age of one.

The new system meets an unmet need because existing chemotherapy treatments for adult cancer patients are not particularly effective for children due to differences in their physiology and in the way pediatric cancer cells grow and spread. In fact, conventional chemotherapy can cause severe damage to an ill child.

While highly targeted nanoparticle delivery systems show great promise in adult cancer patients, studies involving children have been limited. Prof. Alejandro Sosnik of the Technion-Israel Institute of Technology’s Department of Materials Science and Engineering, together with graduate student Alexandra Bukchin, used a mouse model to test their system for the selective transport of the chemotherapeutic drug Dasatinib via nanoscale packaging in young patients.

“The target audience is very physiologically fragmented and therefore less economically viable for pharmaceutical companies,” said Sosnik.

A paper published recently in the Journal of Controlled Release summarizes the three-year study that led to the first success in delivering Dasatinib with the help of these nanoparticles, and the first demonstration of the particles accumulating in the tumor in the patient’s tissue, in a model of pediatric cancer in experimental animals. The research was supported by Technion as well as grants from the European Commission.

(via Israel21c)


Be the first to comment

Please check your e-mail for a link to activate your account.